Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). (Q45754377)
Jump to navigation
Jump to search
scientific article published in June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). |
scientific article published in June 2013 |
Statements
1 reference
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). (English)
1 reference
Centers for Disease Control and Prevention (CDC)
1 reference
1 June 2013
1 reference
1 reference
62
1 reference
25
1 reference
521-524
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference